Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 44

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 44
---
 on our performance against ambitious goals with a modifier based on relative TSR performance. The cash LTIP is intended to: • motivate and reward participants to drive stockholder value by achieving certain performance goals; and • further enhance retention Unlike the annual cash incentive bonus opportunity which is short-term in nature, the cash LTIP is based solely on financial metrics and a TSR multiplier (which further aligns executives’ interests with those of stockholders) and provides cash awards to participants based on the achievement of certain performance goals during each applicable performance period (January 1 through December 31 of each calendar year), with the potential award amount ranging from 0% to 225% of the target cash award. There is also a retention element—if the performance goals are achieved, the cash LTIP awards will then vest in full only after a three-year vesting period, subject to the participant’s continued employment (except in the case of death or disability during the vesting period, or unless otherwise approved by the board or the People & Compensation Committee). The executive officers that participated in the cash LTIP in 2024 earned a cash LTIP payment at 85% of target based on the achieved level of performance for two equally-weighted financial metrics. For more information, see the section titled “2024 Cash LTIP Targets and Earned Awards” on page 66. Total Target Compensation Mix These charts represent the target values granted to our CEO, Frank D. Lee and the average of our other named executive officers in 2024 (excluding Messrs. Stack and Reinhart who were known to be departing, and Ms. Riker who was interim CFO for approximately three weeks). To incentivize them to accept their offers of employment with the Company in the context of a highly competitive market, Messrs. Lee and Cross received larger equity grants in connection with their hirings than would be targeted for them in subsequent years. These targeted values also exclude special retention grants made to Ms. Williams and Mr. Gaugler and a grant to Dr. Slonin of stock options and RSUs in connection with his promtion to Chief Medical Officer. Actual amounts earned can be found within “Compensation Discussion and Analysis” beginning on page 51. 56 | investor.pacira.com

TABLE OF CONTENTS Executive Compensation Compensation Governance Highlights In order to further align the long-term interests of management with those of our stockholders and align our compensation program with corporate governance best practices, The People & Compensation Committee has established the following policies and practices:

| ​ | Things